UM
Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury
Hu J.; Zhu X.-H.; Zhang X.-J.; Wang P.-X.; Zhang R.; Zhang P.; Zhao G.-N.; Gao L.; Zhang X.-F.; Tian S.; Li H.
2016
Source PublicationJournal of Hepatology
ISSN1688278
Volume64Issue:1Pages:146
AbstractBackground & Aims The hallmarks of hepatic ischemia/reperfusion (I/R) injury, a common clinical problem that occurs during liver surgical procedures, include severe cell death and inflammatory responses that contribute to early graft failure and a higher incidence of organ rejection. Unfortunately, effective therapeutic strategies are limited. Tumor necrosis factor receptor (TNFR)-associated factor (TRAF) 3 transduces apoptosis and/or inflammation-related signaling pathways to regulate cell survival and cytokine production. However, the role of TRAF3 in hepatic I/R-induced liver damage remains unknown. Methods Hepatocyte- or myeloid cell-specific TRAF3 knockdown or transgenic mice were subjected to an I/R model in vivo, and in vitro experiments were performed by treating primary hepatocytes from these mice with hypoxia/reoxygenation stimulation. The function of TRAF3 in I/R-induced liver damage and the potential underlying mechanisms were investigated through various phenotypic analyses and biological approaches. Results Hepatocyte-specific, but not myeloid cell-specific, TRAF3 deficiency reduced cell death, inflammatory cell infiltration, and cytokine production in both in vivo and in vitro hepatic I/R models, whereas hepatic TRAF3 overexpression resulted in the opposite effects. Mechanistically, TRAF3 directly binds to TAK1, which enhances the activation of the downstream NF-κB and JNK pathways. Importantly, inhibition of TAK1 almost completely reversed the TRAF3 overexpression-mediated exacerbation of I/R injury. Conclusions TRAF3 is a novel hepatic I/R mediator that promotes liver damage and inflammation via TAK1-dependent activation of the JNK and NF-κB pathways. Inhibition of hepatic TRAF3 may represent a promising approach to protect the liver against I/R injury-related diseases. © 2015 European Association for the Study of the Liver.
KeywordCell death Hepatic ischemia/reperfusion Inflammation TAK1 TRAF3
DOI10.1016/j.jhep.2015.08.021
URLView the original
Language英语
The Source to ArticleScopus
Fulltext Access
Citation statistics
Cited Times [WOS]:38   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Recommended Citation
GB/T 7714
Hu J.,Zhu X.-H.,Zhang X.-J.,et al. Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury[J]. Journal of Hepatology,2016,64(1):146.
APA Hu J..,Zhu X.-H..,Zhang X.-J..,Wang P.-X..,Zhang R..,...&Li H..(2016).Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.Journal of Hepatology,64(1),146.
MLA Hu J.,et al."Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury".Journal of Hepatology 64.1(2016):146.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Hu J.]'s Articles
[Zhu X.-H.]'s Articles
[Zhang X.-J.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Hu J.]'s Articles
[Zhu X.-H.]'s Articles
[Zhang X.-J.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Hu J.]'s Articles
[Zhu X.-H.]'s Articles
[Zhang X.-J.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.